FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin

Print this page INCHEON, KOREA – January 21, 2019 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Ontruzant (trastuzumab-dttb), a biosimilar referencing Herceptin®i (trastuzumab), across all eligible indications, namely adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer and metastatic gastric cancer or gastroesophageal junction adenocarcinoma… Read More »

Amid shutdown, federal workers face health struggles: 'We are the ones that are suffering'

Tamela Worthen hasn’t been able to afford her diabetes medication in a week, she said. Yvette Hicks said that her children haven’t been able to receive their proper asthma treatment. John Kostelnik said he won’t be able to find out whether he has cancer until the shutdown is over. Those are just a few ways… Read More »

Hospitals' confusing online price lists give patients a headache – CBS News

A new federal rule that took effect this year was supposed to make health care costs more transparent by requiring hospitals to disclose their prices to the public. But it may be adding to patients’ confusion. Nicki Pogue’s recent out-of-network emergency room visit for a viral syndrome left her more fearful of her hospital bill… Read More »

  1. Pages:
  3. 1
  4. ...
  5. 720
  6. 721
  7. 722
  8. 723
  9. 724
  10. 725
  11. 726
  12. ...
  13. 1812